Vivitrol Patent Expiration

VIVITROL IPR and PTAB Proceedings
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5916598 ALKERMES Preparation of biodegradable, biocompatible microparticles containing a biologically active agent
May, 2017

(7 years ago)

US5792477 ALKERMES Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent
May, 2017

(7 years ago)

US6403114 ALKERMES Preparation of biodegradable, biocompatible microparticles containing a biologically active agent
May, 2017

(7 years ago)

US6596316 ALKERMES Preparation of microparticles having a selected release profile
Dec, 2018

(5 years ago)

US6194006 ALKERMES Preparation of microparticles having a selected release profile
Dec, 2018

(5 years ago)

US6379703 ALKERMES Preparation of microparticles having a selected release profile
Dec, 2018

(5 years ago)

US6939033 ALKERMES Method and apparatus for preparing microparticles using in-line solvent extraction
Nov, 2019

(4 years ago)

US6537586 ALKERMES Apparatus and method for preparing microparticles
Nov, 2019

(4 years ago)

US6395304 ALKERMES Apparatus and method for preparing microparticles
Nov, 2019

(4 years ago)

US6495166 ALKERMES Apparatus and method for preparing microparticles using in-line solvent extraction
Nov, 2019

(4 years ago)

US6713090 ALKERMES Apparatus and method for preparing microparticles
Nov, 2019

(4 years ago)

US6331317 ALKERMES Apparatus and method for preparing microparticles
Nov, 2019

(4 years ago)

US6534092 ALKERMES Method for preparing microparticles having a selected polymer molecular weight
May, 2020

(4 years ago)

US6379704 ALKERMES Method for preparing microparticles having a selected polymer molecular weight
May, 2020

(4 years ago)

US6264987 ALKERMES Method for preparing microparticles having a selected polymer molecular weight
May, 2020

(4 years ago)

US6495164 ALKERMES Preparation of injectable suspensions having improved injectability
May, 2020

(4 years ago)

US7799345 ALKERMES Preparation of injectable suspensions having improved injectability
May, 2020

(4 years ago)

US6667061 ALKERMES Preparation of injectable suspensions having improved injectability
May, 2020

(4 years ago)

US7919499 ALKERMES Naltrexone long acting formulations and methods of use
Oct, 2029

(5 years from now)



Vivitrol is a drug owned by Alkermes Inc. It is used for treating alcohol dependence. Vivitrol uses Naltrexone as an active ingredient. Vivitrol was launched by Alkermes in 2006. It is is available in for suspension, extended release form for intramuscular use. Its generic launch date based on the last expiry date of its patents and exclusivities combined is estimated to be Oct 15, 2029 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)

Drug Exclusivity Drug Exclusivity Expiration
New Indication(I-631) Oct 12, 2013

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

Drugs and Companies using NALTREXONE ingredient

Market Authorisation Date: 13 April, 2006

Treatment: Treatment of alcohol dependence

Dosage: FOR SUSPENSION, EXTENDED RELEASE

How can I launch a generic of VIVITROL before it's drug patent expiration?
More Information on Dosage

VIVITROL family patents

Family Patents